Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
Irritant and allergic contact dermatitis look similar but arise differently. Here is how patch testing separates them and what it shows about metals, preservatives, silver and chitosan.
WHO halves the albendazole dose for children aged 12–23 months but keeps mebendazole at 500 mg. Here is why, and how a chewable tablet lowers choking risk for toddlers.
A short azithromycin course works because the drug builds up inside cells and tissues and leaves slowly. Here is what the research shows, and what it means for patients.
Fenbendazole and its relatives starve parasites by disabling a single protein, beta-tubulin. Here is how that binding works, why it largely spares the host, and what the body turns fenbendazole into.
For pregnant women with lupus, continuing hydroxychloroquine lowers flare risk and appears safe for the baby. It may also reduce the risk of congenital heart block in anti-Ro-positive mothers.
People heavily infected with Loa loa can suffer brain injury after ivermectin. Measuring microfilarial density first, and deferring the few at risk, has made river blindness treatment safer.
Transepidermal water loss is the laboratory's main measure of skin barrier function. Here is how it is measured, why test conditions matter, and what the readings can and cannot tell you.
A randomized trial in Peru found that adding praziquantel to albendazole cleared all brain cysts in more patients with multiple viable cysts. Here is what it showed and what it did not.
For 40 years no one knew exactly how praziquantel kills blood flukes. Research published in 2021 identified a worm calcium channel as its target, explaining paralysis and skin damage.